The GLP-1 liraglutide showed potential benefit in reducing stroke recurrence and improving functional outcomes after minor ...
A new study breaks down several cases of Ozempic blindness, linked to semaglutide and tirzepatide. Here's what could be behind this.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback